<unk>  is a combination<unk>  whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant)<unk>  (adsorbed) or<unk> -Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014. A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between<unk>  and Hib<unk>  administered separately and pentavalent<unk> -HepB-Hib<unk> .
DTP-HepB vaccine
MMR vaccine
MMRV vaccine
Polio vaccine
Typhus vaccine
DTaP-IPV-HepB vaccine
Rabies vaccine
Ebola vaccine